|
Phase I/II study of low-dose cyclophosphamide, tumor-associated peptide antigen-pulsed dendritic cell and low dose GM-CSF for solid and hematological tumors. |
| |
|
|
Stock and Other Ownership Interests - Kiromic |
| |
|
|
Stock and Other Ownership Interests - Kiromic |
Patents, Royalties, Other Intellectual Property - Kiromic |
| |
|
|
Stock and Other Ownership Interests - Kiromic |
| |
|
No Relationships to Disclose |
| |
Maurizio Chiriva-Internati |
|
|
Stock and Other Ownership Interests - Kiromic |
Patents, Royalties, Other Intellectual Property - Kiromic |